Academic Journals Database
Disseminating quality controlled scientific knowledge

Current perspectives in the treatment of resistant schizophrenia

ADD TO MY LIST
 
Author(s): Solanki R | Singh Paramjeet | Munshi Deepti

Journal: Indian Journal of Psychiatry
ISSN 0019-5545

Volume: 51;
Issue: 4;
Start page: 254;
Date: 2009;
Original page

Keywords: Adjuvant therapy | clozapine | treatment resistance

ABSTRACT
This article summarizes the current knowledge base on the diagnosis and management of treatment resistant schizophrenia. While the prevalence of treatment resistant schizophrenia is definition dependent, estimates have ranged from 30% to up to 60%. This article first looks into the various diagnostic criteria of treatment resistant schizophrenia. Then the literature is reviewed about the pharmacotherapeutics of its management. Clozapine emerges to be the gold standard. In addition risperidone and high dose olanzapine also emerge as clinically useful options. Other emerging adjunctive treatment options are equally addressed.
Affiliate Program      Why do you need a reservation system?